Literature DB >> 31399363

A 4-Item Case-Finding Tool to Detect Dementia in Older Persons.

Tau Ming Liew1.   

Abstract

OBJECTIVES: Brief cognitive tests are recommended in clinical services outside of specialized memory clinics as case-finding tools to reduce the diagnostic gap of dementia. Although the Montreal Cognitive Assessment (MoCA) is among the most widely used brief tests in specialized memory clinics, its length precludes routine use in nonspecialty clinics. This study investigated whether a small subset of MoCA would suffice to match the performance of the full MoCA in detecting dementia and, hence, be useful in nonspecialty clinics.
DESIGN: Cross-sectional test research.
SETTING: Alzheimer's Disease Centers across the United States. PARTICIPANTS: Participants age ≥65 years (n = 8773). MEASURES: Participants completed MoCA and were evaluated for dementia. The study sample was split into 2: the derivation sample (n = 4386) was used to develop a short variant of MoCA that best distinguish dementia (using the best-subset-approach with 10-fold cross-validation), while the validation sample (n = 4387) verified its actual performance using area under the receiver operating characteristic-curve (AUC).
RESULTS: A 4-item cognitive test was identified, comprising Clock-drawing, Tap-at-letter-A, Orientation, and Delayed-recall. It demonstrated excellent performance in distinguishing dementia from nondementia (AUC 94.2%) and was comparable to that of MoCA (AUC 93.8%), even across education subgroups. It explained 85.9% of the variability in MoCA and had scores that could be mapped to MoCA with reasonable precision. At the optimal cut-off score of <10, it demonstrated 87.9% sensitivity and 87.6% specificity in detecting dementia. CONCLUSIONS AND IMPLICATIONS: Using rigorous methods, this study developed a brief cognitive test that is free of charge, takes <5 minutes to complete, covers the key cognitive domains, and has standardized instructions to allow its administration even by nonphysicians. This brief test is well suited as a case-finding tool in nonspecialty clinics (such as in primary care and geriatric clinics) and may improve care-integration with specialized memory clinics that utilize MoCA.
Copyright © 2019 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dementia; Montreal Cognitive Assessment; brief cognitive test; score mapping

Mesh:

Year:  2019        PMID: 31399363      PMCID: PMC6884672          DOI: 10.1016/j.jamda.2019.06.015

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  30 in total

1.  Brain health: the importance of recognizing cognitive impairment: an IAGG consensus conference.

Authors:  John E Morley; John C Morris; Marla Berg-Weger; Soo Borson; Brian D Carpenter; Natalia Del Campo; Bruno Dubois; Keith Fargo; L Jaime Fitten; Joseph H Flaherty; Mary Ganguli; George T Grossberg; Theodore K Malmstrom; Ronald D Petersen; Carroll Rodriguez; Andrew J Saykin; Philip Scheltens; Eric G Tangalos; Joe Verghese; Gordon Wilcock; Bengt Winblad; Jean Woo; Bruno Vellas
Journal:  J Am Med Dir Assoc       Date:  2015-09-01       Impact factor: 4.669

Review 2.  Mild cognitive impairment as a clinical entity and treatment target.

Authors:  Ronald C Petersen; John C Morris
Journal:  Arch Neurol       Date:  2005-07

3.  Screening for dementia with the memory impairment screen.

Authors:  H Buschke; G Kuslansky; M Katz; W F Stewart; M J Sliwinski; H M Eckholdt; R B Lipton
Journal:  Neurology       Date:  1999-01-15       Impact factor: 9.910

4.  equate: Observed-Score Linking and Equating in R.

Authors:  Anthony D Albano
Journal:  Appl Psychol Meas       Date:  2015-12-08

5.  The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database.

Authors:  Duane L Beekly; Erin M Ramos; Gerald van Belle; Woodrow Deitrich; Amber D Clark; Mary E Jacka; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

6.  An Abbreviated Montreal Cognitive Assessment (MoCA) for Dementia Screening.

Authors:  Daniel K Horton; Linda S Hynan; Laura H Lacritz; Heidi C Rossetti; Myron F Weiner; C Munro Cullum
Journal:  Clin Neuropsychol       Date:  2015-05-15       Impact factor: 3.535

7.  The multilingual naming test in Alzheimer's disease: clues to the origin of naming impairments.

Authors:  Iva Ivanova; David P Salmon; Tamar H Gollan
Journal:  J Int Neuropsychol Soc       Date:  2013-01-08       Impact factor: 2.892

8.  Developing a Brief Neuropsychological Battery for Early Diagnosis of Cognitive Impairment.

Authors:  Tau Ming Liew
Journal:  J Am Med Dir Assoc       Date:  2019-04-13       Impact factor: 4.669

9.  A 3-Item Screening Scale for Caregiver Burden in Dementia Caregiving: Scale Development and Score Mapping to the 22-Item Zarit Burden Interview.

Authors:  Tau Ming Liew; Philip Yap
Journal:  J Am Med Dir Assoc       Date:  2018-12-24       Impact factor: 4.669

10.  The Montreal Cognitive Assessment is superior to National Institute of Neurological Disease and Stroke-Canadian Stroke Network 5-minute protocol in predicting vascular cognitive impairment at 1 year.

Authors:  YanHong Dong; Jing Xu; Bernard Poon-Lap Chan; Raymond Chee Seong Seet; Narayanaswamy Venketasubramanian; Hock Luen Teoh; Vijay Kumar Sharma; Christopher Li-Hsian Chen
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

View more
  8 in total

1.  Active case finding of dementia in ambulatory care settings: a comparison of three strategies.

Authors:  T M Liew
Journal:  Eur J Neurol       Date:  2020-06-16       Impact factor: 6.089

2.  Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia.

Authors:  Tau Ming Liew
Journal:  Age Ageing       Date:  2021-09-11       Impact factor: 10.668

3.  Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.

Authors:  Tau Ming Liew
Journal:  Aust N Z J Psychiatry       Date:  2022-03-01       Impact factor: 5.598

4.  Comparative Study of Two Short-Form Versions of the Montreal Cognitive Assessment for Screening of Post-Stroke Cognitive Impairment in a Chinese Population.

Authors:  Jingjing Wei; Xianglan Jin; Baoxin Chen; Xuemei Liu; Hong Zheng; Rongjuan Guo; Xiao Liang; Chen Fu; Yunling Zhang
Journal:  Clin Interv Aging       Date:  2020-06-18       Impact factor: 4.458

5.  Recommendations of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia.

Authors:  Zahinoor Ismail; Sandra E Black; Richard Camicioli; Howard Chertkow; Nathan Herrmann; Robert Laforce; Manuel Montero-Odasso; Kenneth Rockwood; Pedro Rosa-Neto; Dallas Seitz; Saskia Sivananthan; Eric E Smith; Jean-Paul Soucy; Isabelle Vedel; Serge Gauthier
Journal:  Alzheimers Dement       Date:  2020-07-29       Impact factor: 21.566

6.  Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer's and non-Alzheimer's dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-03-31       Impact factor: 6.982

7.  Trajectories of subjective cognitive decline, and the risk of mild cognitive impairment and dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-10-27       Impact factor: 6.982

8.  Subjective cognitive decline, anxiety symptoms, and the risk of mild cognitive impairment and dementia.

Authors:  Tau Ming Liew
Journal:  Alzheimers Res Ther       Date:  2020-09-11       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.